N

Neumora

112 employees

Neumora Therapeutics operates as a clinical-stage biotechnology company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2020

Funding rounds raised

Total raised

$400M

from 16 investors over 16 rounds

N

Neumora raised $112M on October 11, 2022

Investors: Newpath Partners, Abu Dhabi Growth Fund (ADG), ARCH Venture Partners, Polaris Partners, Exor N.V., The Invus Group and F-Prime Capital Partners

N

Neumora raised $400M on October 7, 2021

Investors: re.Mind Capital, Newpath Partners, SoftBank Investment Advisers, Logos Global Management, LP, Surveyor Capital, F-Prime Capital Partners, The Invus Group and Polaris Partners

N

Neumora raised undisclosed on October 1, 2018

Investors: Premier Partners

FAQ